NEUROPHET, Inc. (KOSDAQ:380550)
29,800
-2,800 (-8.59%)
At close: Dec 5, 2025
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 344.31 billion as of December 5, 2025.
Market Cap
344.31B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29,800.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 344.31B, an increase of 47.80%. That is a compound annual growth rate of 194.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 376.66B | 61.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,645.44B |